Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2028

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Introduction
1.2 Market by Type
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Market by Application
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts 2017-2028
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Estimates and Forecasts 2017-2028
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region
2.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022)
2.4.2 Global Sales Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2023-2028)
2.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region
2.5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022)
2.5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturers
3.1.1 Global Top Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers by Sales (2017-2022)
3.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists in 2021
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers
3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2017-2022)
3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2021
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Sales by Type (2017-2022)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Sales by Type (2023-2028)
4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Revenue by Type (2017-2022)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Revenue by Type (2023-2028)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type
4.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2017-2022)
4.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application
5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Sales by Application (2017-2022)
5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Sales by Application (2023-2028)
5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historical Revenue by Application (2017-2022)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Revenue by Application (2023-2028)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application
5.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2017-2022)
5.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2023-2028)
6 North America
6.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
6.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
6.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
6.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
6.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
6.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
6.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
6.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
6.3.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
7.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
7.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
7.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
7.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
7.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
7.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
7.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
7.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
8.1.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
8.1.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
8.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
8.2.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
8.2.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
8.3 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region
8.3.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2028)
8.3.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
9.1.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
9.1.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
9.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
9.2.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
9.2.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
9.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
9.3.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
9.3.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
10.1.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2028)
10.1.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2028)
10.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
10.2.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2028)
10.2.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2028)
10.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
10.3.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2028)
10.3.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Eli Lily
11.3.1 Eli Lily Corporation Information
11.3.2 Eli Lily Overview
11.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lily Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Overview
11.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Amylin
11.7.1 Amylin Corporation Information
11.7.2 Amylin Overview
11.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Amylin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis
12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glucagon Like Peptide-1 (GLP-1) Agonists Production Mode & Process
12.4 Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Marketing
12.4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Channels
12.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
12.5 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
13.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
13.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
13.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
14 Key Findings in The Global Glucagon Like Peptide-1 (GLP-1) Agonists Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Exenatied
Table 3. Major Manufacturers of Liraglutide
Table 4. Major Manufacturers of Lixisenatide
Table 5. Major Manufacturers of Albiglutide
Table 6. Major Manufacturers of Dulaglutide
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022) & (K Units)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2017-2022)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2023-2028) & (K Units)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2023-2028)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2017-2022)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2023-2028)
Table 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers (2017-2022)
Table 19. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2017-2022)
Table 21. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2021)
Table 24. Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
Table 26. Date of Manufacturers Enter into Glucagon Like Peptide-1 (GLP-1) Agonists Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2017-2022)
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2023-2028)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2017-2022)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2023-2028)
Table 36. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 40. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2017-2022)
Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2023-2028)
Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2017-2022)
Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Application (2023-2028)
Table 46. Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 49. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 50. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 53. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 54. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
Table 57. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
Table 58. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 61. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 62. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 65. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 66. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
Table 69. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
Table 70. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2023-2028) & (US$ Million)
Table 108. Novo Nordisk Corporation Information
Table 109. Novo Nordisk Description and Major Businesses
Table 110. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Novo Nordisk Recent Developments
Table 113. AstraZeneca Corporation Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. Eli Lily Corporation Information
Table 119. Eli Lily Description and Major Businesses
Table 120. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Eli Lily Recent Developments
Table 123. GSK Corporation Information
Table 124. GSK Description and Major Businesses
Table 125. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. GSK Recent Developments
Table 128. Sanofi Corporation Information
Table 129. Sanofi Description and Major Businesses
Table 130. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Sanofi Recent Developments
Table 133. Bristol-Myers Squibb Corporation Information
Table 134. Bristol-Myers Squibb Description and Major Businesses
Table 135. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Bristol-Myers Squibb Recent Developments
Table 138. Amylin Corporation Information
Table 139. Amylin Description and Major Businesses
Table 140. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Amylin Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 146. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 147. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Table 148. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Table 149. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 150. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type in 2021 & 2028
Figure 3. Exenatied Product Picture
Figure 4. Liraglutide Product Picture
Figure 5. Lixisenatide Product Picture
Figure 6. Albiglutide Product Picture
Figure 7. Dulaglutide Product Picture
Figure 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Other
Figure 12. Glucagon Like Peptide-1 (GLP-1) Agonists Report Years Considered
Figure 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales 2017-2028 (K Units)
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue 2017-2028 (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2017-2022)
Figure 18. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2023-2028)
Figure 19. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
Figure 20. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists in the World: Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2021
Figure 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2017-2028)
Figure 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2017-2028)
Figure 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2017-2028)
Figure 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2017-2028)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Metformin Hydrochloride Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......

Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......

Global Insulin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......

Global Insulin API Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Glucagon Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Acarbose Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global Insulin Glargine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77

According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......

Global Liraglutide Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103

According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs